Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DBV Technologies S.A.DBVT · Entity 5096 | Chief Commercial Officer | November 21, 2025 | November 24, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DBV Technologies S.A.
Report date November 21, 2025 · Filed November 24, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 55,000 |
Reported balance
After 2025-11-21 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-11-21 · Grant · Acquired 55,000 · Balance 55,000 F1: The ordinary shares may be represented by American Depositary Shares, each of which currently represents five ordinary shares. F2: Represents the Issuer's ordinary shares underlying a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one ordinary share. The RSUs shall vest in four equal annual installments commencing on November 21, 2026, subject to the Reporting Person continuing to provide service through each such date. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.90 · Expires 2035-11-21 | Direct | 316,250 |
Reported balance
After 2025-11-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-11-21 · Grant · Acquired 316,250 · Balance 316,250 F3: This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.15154 to EURO 1.00 as of November 21, 2025. F4: The option shall vest in four equal annual installments commencing on November 21, 2026, subject to the Reporting Person continuing to provide service through each such date. |
Filing footnotes · ownership attribution and instrument terms
F1: The ordinary shares may be represented by American Depositary Shares, each of which currently represents five ordinary shares.
F2: Represents the Issuer's ordinary shares underlying a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one ordinary share. The RSUs shall vest in four equal annual installments commencing on November 21, 2026, subject to the Reporting Person continuing to provide service through each such date.
F3: This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.15154 to EURO 1.00 as of November 21, 2025.
F4: The option shall vest in four equal annual installments commencing on November 21, 2026, subject to the Reporting Person continuing to provide service through each such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 21, 2025 Filed Nov 24, 2025 19:05 UTC | DBV Technologies S.A. DBVT · Entity 5096 | GrantEmployee Stock Option (right to buy) · Derivative | 316,250 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0002096014-25-000004 · form4-11242025_071103.xml · derivative · entry 2 Trapp Kevin Michael · CIK 0002096014 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 316,250 Underlying: Ordinary Shares · 316,250 shares Expires 2035-11-21 F3 · derivative.exercise_price: This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.15154 to EURO 1.00 as of November 21, 2025. F4 · derivative.exercise_date: The option shall vest in four equal annual installments commencing on November 21, 2026, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| November 21, 2025 Filed Nov 24, 2025 19:05 UTC | DBV Technologies S.A. DBVT · Entity 5096 | GrantOrdinary Shares | 55,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002096014-25-000004 · form4-11242025_071103.xml · nonDerivative · entry 1 Trapp Kevin Michael · CIK 0002096014 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 F1 · security: The ordinary shares may be represented by American Depositary Shares, each of which currently represents five ordinary shares. F2 · kind: Represents the Issuer's ordinary shares underlying a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one ordinary share. The RSUs shall vest in four equal annual installments commencing on November 21, 2026, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.